Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Rocky Brands | RCKY | Nov 5, 2024 | 20.32 | -2.17 |
Rocky Mountain Chocolate Factory | RMCF | Nov 5, 2024 | 2.68 | +3.47 |
Rogers | ROG | Nov 5, 2024 | 103.82 | +1.91 |
Rogers Communications | RCI | Nov 5, 2024 | 37.29 | +1.72 |
Roivant Sciences | ROIV | Nov 5, 2024 | 11.66 | +1.13 |
Roku A | ROKU | Nov 5, 2024 | 69.67 | +3.71 |
Rollins | ROL | Nov 5, 2024 | 48.55 | +1.44 |
Roma Green Finance | ROMA | Nov 5, 2024 | 1.01 | +1.00 |
Root | ROOT | Nov 5, 2024 | 70.98 | +0.03 |
Roper Technologies | ROP | Nov 5, 2024 | 542.70 | +0.11 |
Ross Stores | ROST | Nov 5, 2024 | 142.32 | +1.18 |
Roth CH Acquisition V | ROCL | Nov 5, 2024 | 11.34 | 0.00 |
Roth CH Acquisition V Unit | ROCLU | Nov 5, 2024 | 11.90 | 0.00 |
Royal Bank Of Canada | RY | Nov 5, 2024 | 123.15 | +0.72 |
Royal Caribbean Cruises | RCL | Nov 5, 2024 | 210.77 | +3.12 |
Royal Gold | RGLD | Nov 5, 2024 | 148.24 | +1.97 |
Royalty Management Holding A | RMCO | Nov 5, 2024 | 1.06 | -3.64 |
Royalty Pharma Plc | RPRX | Nov 5, 2024 | 27.54 | +1.25 |
Royce Global Value Trust | RGT | Nov 5, 2024 | 11.48 | +0.79 |
Royce Micro-Cap Trust | RMT | Nov 5, 2024 | 9.56 | +2.14 |
Royce Small-Cap Trust | RVT | Nov 5, 2024 | 15.42 | +1.51 |
RPC | RES | Nov 5, 2024 | 5.88 | +3.52 |
RPM International | RPM | Nov 5, 2024 | 129.51 | +1.54 |
RTX | RTX | Nov 5, 2024 | 118.98 | +0.83 |
Rubrik | RBRK | Nov 5, 2024 | 41.55 | +0.07 |
Rumble | RUM | Nov 5, 2024 | 5.95 | +3.12 |
RumbleOn B | RMBL | Nov 5, 2024 | 5.18 | +4.23 |
Runway Growth Finance | RWAY | Nov 5, 2024 | 9.99 | +0.20 |
Rush Enterprises A | RUSHA | Nov 5, 2024 | 59.50 | +2.44 |
Rush Enterprises B | RUSHB | Nov 5, 2024 | 52.21 | +3.32 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.